Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of adverse events with SOX plus intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis in low-experience hospitals
jRCTs031180433Completed
- Sponsor
- Jichi Medical University Hospital
- Start
- May 2017
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur, oxaliplatin and paclitaxel in gastric adenocarcinoma and peritoneal carcinomatosis (PC), sponsored by Jichi Medical University Hospital. Primary endpoint: Kinds and frequency of adverse events. Started May 2017; status: completed.
02
Drugs
tegafuroxaliplatinpaclitaxel
03
Conditions
gastric adenocarcinomaperitoneal carcinomatosis (PC)
Beyond the preview
Go deeper on jRCTs031180433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180433.